Testimonials

It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China

Blog

Blog

Home / Blog

A Highly Sensitive LC-MS/MS Method for the Quantification of Formoterol in Human plasma.

31 Jan 2019

Background:

Formoterol is a long-acting β2 agonist (LABA) used as a Bronchodilator in the management of asthma and chronic obstructive pulmonary disease. Recommended low doses are to be used as over dosing may lead to nausea, vomiting, headache, tremor, somnolence, palpitations, tachycardia, ventricular arrhythmias, metabolic acidosis, hypokalemia and hyperglycemia. Formoterol is used in powder form for inhalation. Due to this, a very low detection (sub pico gram level detection) in plasma is required for proper characterization of PK studies. Hence, a selective and sensitive method at a LLOQ of 0.4 pg/mL in human plasma has been developed.
 
Bioanalytical method:

The method for the quantification of Formoterol involves double extraction procedure i.e. protein precipitation followed by solid phase extraction to get rid of matrix effect. Formoterol-d6 has been used as internal standards (ISTD).  Chromatographic separation was achieved on Biphenyl 5µ, 100*4.6 mm column with a mobile phase consisting of 5 mM of ammonium formate buffer and methanol with gradient time program, with a total run-time of 9.0 minutes. Detection was carried out in positive electro-spray ionization mode using MRM transitions of 345.05→149.20 and 351.05→152.30 for Formoterol and Formoterol d6 respectively.
 
The method was validated in terms of linearity, stabilities and as per regulatory requirements. The validated method has a linearity range from 0.4 to 150 pg/mL for Formoterol. As Formoterol is unstable in blood, a stabilizer (buffer) has been used during the blood collection and plasma from the same has been used for the stability purpose and found to be stable in buffered plasma under the assay conditions. Excellent precision and accuracy were observed even at a LLOQ level i.e. 0.4pg/mL. Also, there was no matrix effect observed in normal human lots.
 
Conclusion:

The validated method is suitable for the analysis of samples from a single oral dose of 24 µg powder for inhalation dose under fasting condition to humans and will be applied to the analysis of study samples.
 
To conclude, a selective, simple, precise, accurate and highly sensitive LC-MS/MS method is now available for quantification of Formoterol in human plasma.





Looking for a Globally Proven Research Partner?

Contact Us